XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Condensed Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Sep. 30, 2021   5,987      
Beginning balance at Sep. 30, 2021 $ 49,622 $ 5,987 $ 11,118 $ 41,596 $ (9,079)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (73)     (52) (21)
Performance and restricted share expense 306   306    
Share transactions under equity-based plans (in shares)   53      
Share transactions under equity-based plans (107) $ 53 (160)    
Ending balance (in shares) at Mar. 31, 2022   6,040      
Ending balance at Mar. 31, 2022 49,748 $ 6,040 11,264 41,544 (9,100)
Beginning balance (in shares) at Dec. 31, 2021   6,003      
Beginning balance at Dec. 31, 2021 45,981 $ 6,003 11,156 37,905 (9,083)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income 3,622     3,639 (17)
Performance and restricted share expense 145   145    
Share transactions under equity-based plans (in shares)   37      
Share transactions under equity-based plans 0 $ 37 (37)    
Ending balance (in shares) at Mar. 31, 2022   6,040      
Ending balance at Mar. 31, 2022 $ 49,748 $ 6,040 11,264 41,544 (9,100)
Beginning balance (in shares) at Sep. 30, 2022 6,040 6,040      
Beginning balance at Sep. 30, 2022 $ 40,690 $ 6,040 11,387 31,956 (8,693)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (4,387)     (4,956) 569
Performance and restricted share expense 207   207    
Share transactions under equity-based plans (in shares)   68      
Share transactions under equity-based plans $ (71) $ 68 (139)    
Ending balance (in shares) at Mar. 31, 2023 6,108 6,108      
Ending balance at Mar. 31, 2023 $ 36,439 $ 6,108 11,455 27,000 (8,124)
Beginning balance (in shares) at Dec. 31, 2022   6,072      
Beginning balance at Dec. 31, 2022 38,573 $ 6,072 11,406 29,367 (8,272)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Comprehensive (loss) income (2,219)     (2,367) 148
Performance and restricted share expense 85   85    
Share transactions under equity-based plans (in shares)   36      
Share transactions under equity-based plans $ 0 $ 36 (36)    
Ending balance (in shares) at Mar. 31, 2023 6,108 6,108      
Ending balance at Mar. 31, 2023 $ 36,439 $ 6,108 $ 11,455 $ 27,000 $ (8,124)